FDX1 and neoplasm: The incorporation of ES into Cu-MOFs nanoplatform has demonstrated potential to induce cuproptosis burst in an FDX1-dependent manner and stimulate tumor cell death in an immunogenic manner, thus improving the survival rate of tumor-bearing mice.